Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Shexiang Baoxin Pillmuskardia

Research Leaders

13 sponsors active, led by Ceneral Hospital Of Benxi Iron And Steel of Liaoning Health Industry Group

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04897126Phase 4CompletedPrimary

Efficacy and Safety of Shexiang Baoxin Pill in Patients With Ischemia With Non-Obstructive Coronary Artery

NCT05714319Recruiting

Intracoronary Provocative Test With Acetylcholine in Patients With INOCA and MINOCA

Showing all 2 trials

Research Network

Common Treatments

  • Shexiang Baoxin Pillmuskardia1
  • Clinical Followup1
  • Data Collection1

Active Sponsors

  • Ceneral Hospital Of Benxi Iron And Steel of Liaoning Health Industry Group1
  • Shanxi Cardiovascular Hospital1
  • Tangshan Central Hospital1
  • Shanghai Changzheng Hospital1
  • The First Hospital of Hebei Medical University1

Top Investigators

Related Conditions

  • Angina Pectoris1
  • Coronary Heart Disease1
  • X Syndrome Angina1
  • Myocardial Infarction With Nonobstructive Coronary Artery1

Activity Timeline